IMCR (STOCKS)
Immunocore Holdings plc American Depositary Shares
$31.470000
+0.420000 (+1.35%)
Prev close: $31.050000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Bahija Jallal
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,591.64M
- Employees
- 493
- P/E (TTM)
- -44.42
- P/B (TTM)
- 4.15
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
11
Buy
5
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.60 | $-0.25 | -0.3519 | -141.84% |
|
Sep 2025 (Q3)
|
$0.00 | $-0.27 | +0.2664 | +100.00% |
|
Jun 2025 (Q2)
|
$-0.20 | $-0.20 | +0.0006 | +0.30% |
|
Mar 2025 (Q1)
|
$0.10 | $-0.40 | +0.4973 | +125.17% |
Financial Statements
| Revenues | $400.02M |
| Benefits Costs and Expenses | $419.12M |
| Cost Of Revenue | $5.09M |
| Costs And Expenses | $419.12M |
| Gross Profit | $394.93M |
| Operating Expenses | $440.28M |
| Selling, General, and Administrative Expenses | $165.41M |
| Research and Development | $274.87M |
| Operating Income/Loss | -$45.35M |
| Income/Loss From Continuing Operations After Tax | -$35.51M |
| Income/Loss From Continuing Operations Before Tax | -$19.10M |
| Income Tax Expense/Benefit | $16.41M |
| Income Tax Expense/Benefit, Current | $1.62M |
| Income Tax Expense/Benefit, Deferred | $14.79M |
| Net Income/Loss | -$35.51M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$35.51M |
| Net Income/Loss Available To Common Stockholders, Basic | -$35.51M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.71 |
| Diluted Earnings Per Share | -$0.71 |
| Basic Average Shares | 50,345,666 |
| Diluted Average Shares | 50,345,666 |
| Assets | $1.07B |
| Current Assets | $996.74M |
| Inventory | $6.74M |
| Prepaid Expenses | $17.98M |
| Other Current Assets | $972.03M |
| Noncurrent Assets | $70.53M |
| Fixed Assets | $11.46M |
| Other Non-current Assets | $59.07M |
| Liabilities | $686.24M |
| Current Liabilities | $246.70M |
| Accounts Payable | $24.36M |
| Wages | $16.54M |
| Other Current Liabilities | $205.79M |
| Noncurrent Liabilities | $439.54M |
| Equity | $381.03M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $381.03M |
| Liabilities And Equity | $1.07B |
| Net Cash Flow From Operating Activities | -$10.71M |
| Net Cash Flow From Operating Activities, Continuing | -$10.71M |
| Net Cash Flow From Investing Activities | -$16.34M |
| Net Cash Flow From Investing Activities, Continuing | -$16.34M |
| Net Cash Flow From Financing Activities | $12.37M |
| Net Cash Flow From Financing Activities, Continuing | $12.37M |
| Exchange Gains/Losses | $26.66M |
| Net Cash Flow | $11.98M |
| Net Cash Flow, Continuing | -$14.68M |
| Comprehensive Income/Loss | -$29.84M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$29.84M |
| Other Comprehensive Income/Loss | $5.68M |